Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pancreatic Neoplasms 3Neuroendocrine Tumors 3Prostatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Liver Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Carcinoid Tumor 2Uveal Melanoma 1Thyroid Neoplasms 1Sarcoma, Synovial 1Prolactinoma 1Prolactin-Producing Pituitary Tumor 1Primary Inoperable Thymoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pituitary Neoplasms 1Peritoneal Neoplasms 1Pancreatic Fistula 1Neoplasms 1Nelson Syndrome 1Myelodysplastic Syndromes 1Meningioma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Hematologic Neoplasms 1

Interventions

pasireotide 14-amino-4'-hydroxylaminodiphenylsulfone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Prolactin-Producing Pituitary Tumor × pasireotide × Clear all
NCT06295952 2026-03-04

A Study of Pasireotide in People With Prolactinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
10 enrolled
Endocrine

Prolactin-Producing Pituitary Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡